Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben-Horin

Showing results (301-310 of 362) with videos related to

Pageof 37
Sort By:
Clinical and Translational Gastroenterology|March 17, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal AdenocarcinomaDoron Yablecovitch, Shomron Ben-Horin, Orit Picard, et al.
Neuro-Oncology|October 23, 2023
Frequencies of 4 tumor-infiltrating lymphocytes potently predict survival in glioblastoma, an immune desertRotem Gershon, Antonina Polevikov, Yevgeny Karepov, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspectsMatthieu Allez, Konstantinos Karmiris, Edouard Louis, et al.
Therapeutic Advances in Gastroenterology|October 23, 2019
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a <i>post hoc</i> analysisDoron Yablecovitch, Uri Kopylov, Adi Lahat, et al.
Gut|January 20, 2022
Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBDBella Ungar, Miri Yavzori, Ella Fudim, et al.
Journal of Crohn'S & Colitis|September 11, 2023
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II StudySivan Harnik, Chaya M Abitbol, Ola Haj Natour, et al.
Gastroenterology Report|June 15, 2026
Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled studyOffir Ukashi, May Tzur, Doron Yablecovitch, et al.
Journal of Crohn'S & Colitis|December 19, 2018
Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBDK Gatt, J Schembri, K H Katsanos, et al.
Inflammatory Bowel Diseases|April 13, 2021
Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn DiseaseGanit Goren, Doron Schwartz, Michael Friger, et al.
Inflammatory Bowel Diseases|May 3, 2018
Real-Time Shear Wave Ultrasound Elastography Differentiates Fibrotic from Inflammatory Strictures in Patients with Crohn's DiseaseYu-Jun Chen, Ren Mao, Xue-Hua Li, et al.
Pageof 37

Showing results (301-310 of 362) with videos related to

Sort By:
Pageof 37
Clinical and Translational Gastroenterology|March 17, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal AdenocarcinomaDoron Yablecovitch, Shomron Ben-Horin, Orit Picard, et al.
Neuro-Oncology|October 23, 2023
Frequencies of 4 tumor-infiltrating lymphocytes potently predict survival in glioblastoma, an immune desertRotem Gershon, Antonina Polevikov, Yevgeny Karepov, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspectsMatthieu Allez, Konstantinos Karmiris, Edouard Louis, et al.
Therapeutic Advances in Gastroenterology|October 23, 2019
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a <i>post hoc</i> analysisDoron Yablecovitch, Uri Kopylov, Adi Lahat, et al.
Gut|January 20, 2022
Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBDBella Ungar, Miri Yavzori, Ella Fudim, et al.
Journal of Crohn'S & Colitis|September 11, 2023
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II StudySivan Harnik, Chaya M Abitbol, Ola Haj Natour, et al.
Gastroenterology Report|June 15, 2026
Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled studyOffir Ukashi, May Tzur, Doron Yablecovitch, et al.
Journal of Crohn'S & Colitis|December 19, 2018
Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBDK Gatt, J Schembri, K H Katsanos, et al.
Inflammatory Bowel Diseases|April 13, 2021
Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn DiseaseGanit Goren, Doron Schwartz, Michael Friger, et al.
Inflammatory Bowel Diseases|May 3, 2018
Real-Time Shear Wave Ultrasound Elastography Differentiates Fibrotic from Inflammatory Strictures in Patients with Crohn's DiseaseYu-Jun Chen, Ren Mao, Xue-Hua Li, et al.
Pageof 37